The 39-item Parkinson's Disease Questionnaire, and particularly its summary index (PDQ-39SI) is a widely used patient-reported clinical trial endpoint. A basic assumption when summing items into a total score is that they represent a common variable. We therefore assessed the unidimensionality of the PDQ-39SI using Rasch and confirmatory factor analysis. Both analyses showed model misfit. Adjustment for differential item functioning and disordered response category thresholds did not improve model fit, and residual analyses showed deviation from unidimensionality. These data indicate multidimensionality and challenge the interpretation and validity of PDQ-39SI scores. Clinicians and investigators should use and interpret the PDQ-39SI with caution.
Andrich, D. (1988) Rasch Models for Measurement. Beverly Hills: SAGE Publications.
2.
Andrich, D., Sheridan, B. and Luo, G. (2004-2005) Interpreting Rumm. Perth: RUMM Laboratory Pty.
3.
Borsboom, D. (2006) When does measurement invariance matter? Med Care44: S176-181.
4.
Bushnell, D.M. and Martin, M.L. (1999) Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res8: 345-350.
5.
Doward, L.C., Meads, D.M. and Thorsen, H. (2004) Requirements for quality of life instruments in clinical research. Value Health7(Suppl. 1): S13-S16.
6.
Floyd, F.J. and Widaman, K.F. (1995) Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess7: 286-299.
7.
Food and Drug Administration (2006) Patient-reported outcome measures: use in medicinal product development to support labelling claims. Federal Register71: 5862-5863.
8.
Franchignoni, F., Giordano, A. and Ferriero, G. (2008) Rasch analysis of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8). Qual Life Res17: 541-548.
9.
Gibb, W.R. and Lees, A.J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry51: 745-752.
Hagell, P. and McKenna, S.P. (2003) International use of health status questionnaires in Parkinson's disease: translation is not enough. Parkinsonism Relat Disord10: 89-92.
12.
Hagell, P. and Nygren, C. (2007) The 39 item Parkinson's Disease Questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry78: 1191-1198.
13.
Hagquist, C. (2001) Evaluating composite health measures using Rasch modelling: an illustrative example. Soz Praventivmed46: 369-378.
14.
Hagquist, C. and Andrich, D. (2004) Is the sense of coherence instrument applicable on adolescents? A latent trait analysis using Rasch modelling. Pers Individ Diff36: 955-968.
Hobart, J. (2003) Rating scales for neurologists. J Neurol Neurosurg Psychiatry74(Suppl. 4): iv22-iv26.
17.
Hoehn, M.M. and Yahr, M.D. (1967) Parkinsonism: onset, progression and mortality . Neurology17: 427-442.
18.
Holland, P.W. and Wainer, H. (1993) Differential Item Functioning. Mahwah: Lawrence Erlbaum Associates.
19.
Jenkinson, C. and Fitzpatrick, R. (2007) Cross-cultural evaluation of the short form 8-Item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. Parkinsonism Relat Disord13: 22-28.
20.
Jenkinson, C., Fitzpatrick, R., Norquist, J., Findley, L. and Hughes, K. (2003a) Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain . J Clin Epidemiol56: 843-847.
21.
Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R. and Hyman, N. (1997) The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease Summary Index Score. Age Ageing26: 353-357.
22.
Jenkinson, C., Norquist, J.M. and Fitzpatrick, R. (2003b) Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5). J Neurol Neurosurg Psychiatry74: 242-245.
23.
Kim, M.Y., Dahlberg, A. and Hagell, P. (2006) Respondent burden and patient-perceived validity of the PDQ-39. Acta Neurol Scand113: 132-137.
24.
Luo, N., Tan, L.C., Li, S.C., Soh, L.K. and Thumboo, J. (2005) Validity and reliability of the Chinese (Singapore) version of the Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res14: 273-279.
25.
Nunnally, J.C. and Bernstein, I.H. (1994) Psychometric Theory, 3rd edition. New York: McGraw-Hill .
26.
Pallant, J.F. and Tennant, A. (2007) An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol46: 1-18.
27.
Paterson, C., Allen, J.A., Browning, M., Barlow, G. and Ewings, P. (2005) A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvement. Complement Ther Clin Pract11: 161-171.
28.
Peto, V., Jenkinson, C., Fitzpatrick, R. and Greenhall, R. (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res4: 241-248.
29.
Rasch, G. (1960) Probabilistic Models for Some Intelligence and Attainment Tests. Copenhagen: Danmarks Paedagogiske Institut.
30.
Schermelleh-Engel, K. and Moosbrugger, H. (2003) Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res Online8: 23-74.
31.
Skevington, S.M. and Tucker, C. (1999) Designing response scales for cross-cultural use in health care: data from the development of the UK WHOQOL. Br J Med Psychol72(Pt 1): 51-61.
32.
Smith, Jr E.V. (2002) Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas3: 205-231.
33.
Smith, R.M. (1996) A comparison of methods for determining dimensionality in Rasch measurement. Structural Equation Modeling3: 25-40.
34.
Stout, W. (1987) A nonparametric approach for assessing latent trait unidimensionality. Psychometrika52: 589-617.
35.
Szabo, S. et al., (on behalf of the WHOQOL Group) (1996) The World Health Organization Quality of Life (WHOQOL) assessment instrument, in Spilker, B., (ed.), Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edition. Philadelphia: Lippincott-Raven Publishers.
36.
Tan, L.C., Luo, N., Nazri, M., Li, S.C. and Thumboo, J. (2004) Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore. Parkinsonism Relat Disord10: 493-499.
37.
Tennant, A., McKenna, S.P. and Hagell, P. (2004a) Application of Rasch analysis in the development and application of quality of life instruments. Value Health7(Suppl. 1): S22-26.
38.
Tennant, A. and Pallant, J. (2006) Unidimensionality matters. Rasch Meas Trans20: 1048-1051.
39.
Tennant, A., Penta, M., Tesio, L., Grimby, G., Thonnard, J.L., Slade, A. et al. (2004b) Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the Pro-Esor project . Med Care42: 137-148.
40.
Wilson, M. (2005) Constructing Measures: An Item Response Modelling Approach. Mahwah: Lawrence Erlbaum Associates.
